---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-000903"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2022-07-26T23:59:59+00:00"
generated_at: "2026-06-24T08:59:52.554608+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# USANA Q2 net sales $264M (-21% YoY), EPS $1.00 (-47%); FY2022 outlook reiterated

## Summary
- Net sales $264M (-21% YoY, -18% constant currency); diluted EPS $1.00 vs $1.87 prior year.
- Active customers 559K (-14% YoY); Greater China active customers 278K (-8% YoY, +9% sequentially).
- FY2022 guidance maintained: net sales $1.015B-$1.065B, diluted EPS $3.85-$4.45.
- No share repurchases during quarter; cash $230M; $83M remaining under buyback authorization.
- COVID disruptions in mainland China and other key markets drove underperformance; inflationary pressures noted.

## SEC filing metadata
- accession: 0001157523-22-000903
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2022-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752322000903/0001157523-22-000903-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752322000903/a52792490.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-000903
- JSON: https://secwatch.observer/filing/0001157523-22-000903.json
- Plain text: https://secwatch.observer/filing/0001157523-22-000903.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.